Jul 13, 2019
Venkat Nelabhotla, Chief Executive Officer, Vyome Therapeutics discusses the growing problem of antimicrobial resistance in medicine and how Vyome is working to tackle resistant dermatological conditions using their understanding of the skin microbiome.
Focusing first on acne, Vyome is developing VB-1953, a topical gel...
Jul 10, 2019
Venkat Nelabhotla, Chief Executive Officer, Vyome Therapeutics discusses the growing problem of antimicrobial resistance in medicine and how Vyome is working to tackle resistant dermatological conditions using their understanding of the skin microbiome. Focusing first on acne, Vyome is developing VB-1953, a topical gel...